SCHEMBL28018331

SCHEMBL28018331

CC=Cc1ccc(Nc2ncnc3ccccc23)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.65
RAB9A P51151 3/20 0.65
POLB P06746 1/20 0.65
MAPK1 P28482 1/20 0.65
ABCG2 Q9UNQ0 7/20 0.65
EGFR P00533 7/20 0.65
ERBB2 P04626 2/20 0.65
AURKB Q96GD4 2/20 0.65
CLK4 Q9HAZ1 2/20 0.65
DAPK3 O43293 1/20 0.65
MAP4K4 O95819 1/20 0.65
ABL1 P00519 1/20 0.65
PIM1 P11309 1/20 0.65
PRKACA P17612 1/20 0.65
LTK P29376 1/20 0.65
MAPK8 P45983 1/20 0.65
CSNK1A1 P48729 1/20 0.65
RPS6KA3 P51812 1/20 0.65
LIMK1 P53667 1/20 0.65
MAP2K1 Q02750 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28181386 1.00 NPC1 (0.65) NPC1RAB9APOLBMAPK1ABCG2
SCHEMBL28324897 0.88 EGFR (0.73) NPC1RAB9APOLBMAPK1ABCG2
SCHEMBL28324896 0.88 EGFR (0.73) NPC1RAB9APOLBMAPK1ABCG2
Hydrochloric Acid SCHEMBL8810099 0.87 EGFR (0.71) NPC1RAB9APOLBMAPK1ABCG2
SCHEMBL28180909 0.81 MAPT (0.50) NPC1MAPK1EGFRHTTSMN1; SMN2
SCHEMBL28851859 0.81 EGFR (0.58) NPC1RAB9APOLBMAPK1ABCG2
SCHEMBL8920 0.80 EGFR (1.00) NPC1RAB9APOLBMAPK1ABCG2
SCHEMBL29941271 0.80 EGFR (1.00) NPC1RAB9APOLBMAPK1ABCG2
SCHEMBL28181381 0.80 EGFR (0.53) ABCG2EGFRERBB2AURKBKDR
Hydrochloric Acid SCHEMBL8808235 0.79 EGFR (0.90) NPC1RAB9APOLBMAPK1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105017162-A 4-P-propenylphenylaminoquinazoline derivative and application thereof in preparation of antitumor drugs UNIV SHAANXI NORMAL 2015-11-04 CN disclosed